Cointime

Gentronix

company

About

Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.

  • 11 - 50

Highlights

Total Funding Amount
£700K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£700K
Industries
Biotechnology,Chemical,Cosmetics
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Active

gentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries.

Their primary focus is on providing better hazard identification assays for genotoxicity through the use of their patented human cell GADD45a reporter assays GreenScreen® HC and BlueScreen HC.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£700K
Gentronix has raised a total of £700K in funding over 2 rounds. Their latest funding was raised on Nov 15, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 15, 2021 Series Unknown £700K 1 Mercia Fund Managers — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Gentronix is funded by 1 investors. Mercia Fund Managers are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Yes Series Unknown
Cointime
İçerikler
Şirket.